Loxapine
Back to searchMolecule Structure
Scientific Name
Loxapine
Description of the Drug
Loxapine is a antipsychotic used for the treatment of schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00408
http://www.drugbank.ca/drugs/DB00408
Brand Name(s)
Adasuve, Loxitane-c oral suspension [as hydrochloride], Loxitane intramuscular [as hydrochloride]
Company Owner(s)
Watson Laboratories Inc, Elite Laboratories Inc, Rising Pharma Holding Inc, Teva Branded Pharmaceutical Products R And D Inc, Alexza Pharmaceuticals Inc, Lannett Co Inc, Actavis Laboratories Ut Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
| Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL94146 | |||
| PharmGKB | PA450273 | |||
| Human Metabolome Database | HMDB0014552 | |||
| DrugBank | DB00408 | |||
| PubChem: Thomson Pharma | 14875092 | |||
| PubChem | 3964 | |||
| LINCS | LSM-2881 | |||
| Nikkaji | J22.645I | |||
| BindingDB | 22871 | |||
| EPA CompTox Dashboard | DTXSID7023229 | |||
| DrugCentral | 1613 | |||
| Brenda | 122953 | |||
| Guide to Pharmacology | 205 | |||
| rxnorm | ADASUVE | LOXAPINE SUCCINATE | LOXAPINE HYDROCHLORIDE | LOXAPINE |
| KEGG Ligand | C07104 | |||
| ChEBI | 50841 | |||
| ZINC | ZINC000019796158 |
